Abstract |
Serotonin (5-hydroxytryptamine, 5-HT)2A receptor agonists have recently emerged as promising new treatment options for a variety of disorders. The recent success of these agonists, also known as psychedelics, like psilocybin for the treatment of anxiety, depression, obsessive-compulsive disorder (OCD), and addiction, has ushered in a renaissance in the way these compounds are perceived in the medical community and populace at large. One emerging therapeutic area that holds significant promise is their use as anti-inflammatory agents. Activation of 5-HT2A receptors produces potent anti-inflammatory effects in animal models of human inflammatory disorders at sub-behavioural levels. This review discusses the role of the 5-HT2A receptor in the inflammatory response, as well as highlight studies using the 5-HT2A agonist (R)-2,5-dimethoxy-4-iodoamphetamine [(R)-DOI] to treat inflammation in cellular and animal models. It also examines potential mechanisms by which 5-HT2A agonists produce their therapeutic effects. Overall, psychedelics regulate inflammatory pathways via novel mechanisms, and may represent a new and exciting treatment strategy for several inflammatory disorders.
|
Authors | Thomas W Flanagan, Charles D Nichols |
Journal | International review of psychiatry (Abingdon, England)
(Int Rev Psychiatry)
Vol. 30
Issue 4
Pg. 363-375
(08 2018)
ISSN: 1369-1627 [Electronic] England |
PMID | 30102081
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Amphetamines
- Anti-Inflammatory Agents
- Hallucinogens
- Receptor, Serotonin, 5-HT2A
- Psilocybin
- 4-iodo-2,5-dimethoxyphenylisopropylamine
|
Topics |
- Amphetamines
(administration & dosage, pharmacology)
- Animals
- Anti-Inflammatory Agents
(administration & dosage, pharmacology)
- Anxiety
(psychology)
- Behavior, Animal
(drug effects)
- Depression
(psychology)
- Hallucinogens
(administration & dosage, pharmacology)
- Humans
- Obsessive-Compulsive Disorder
(psychology)
- Psilocybin
(administration & dosage)
- Receptor, Serotonin, 5-HT2A
(metabolism)
|